Clinical evaluation of [Oxycodone] involves careful consideration of its pharmacokinetics, which dictate how the drug is absorbed, distributed, metabolized, and excreted by the body. Following oral administration, immediate-release formulations typically reach peak plasma concentrations within one to two hours, offering rapid onset of relief for acute breakthrough pain. Conversely, extended-release formulations are engineered using specialized polymer matrix systems designed to release the active pharmaceutical ingredient gradually over a 12-hour period, ensuring stable, sustained therapeutic blood levels for chronic pain management regimens. Understanding these distinct pharmacokinetic profiles is vital for both prescribing physicians and patients to prevent inadvertent overdose and maintain consistent therapeutic efficacy. ?